Pituitary masses: The importance of a multidisciplinary approach

Medical Journal of Australia

Volumn 187, Issue 9, 2007, Pages 522-523

  Inder, Warrick J ^a,b   Alford, Frank P ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; PROLACTIN; THYROXINE;

ACROMEGALY; ACTH SECRETING ADENOMA; ARTICLE; AUSTRALIA; CANCER RADIOTHERAPY; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG RESPONSE; GERM CELL TUMOR; GROWTH HORMONE SECRETING ADENOMA; HISTIOCYTOSIS X; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; HYPOPHYSITIS; HYPOPITUITARISM; INTERDISCIPLINARY COMMUNICATION; MEDICAL SPECIALIST; NONFUNCTIONING PITUITARY ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PREOPERATIVE TREATMENT; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SURGEON; TEAMWORK; THYROTROPIN SECRETING ADENOMA; TRANSSPHENOIDAL HYPOPHYSECTOMY; ADENOMA; HYPOPHYSIS DISEASE; MEDICINE; PATIENT CARE;

ADENOMA; HUMANS; PATIENT CARE TEAM; PITUITARY DISEASES; PITUITARY NEOPLASMS; PROLACTINOMA; REFERRAL AND CONSULTATION; SPECIALTIES, MEDICAL;

EID: 38449095253     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb01395.x     Document Type: Article

References (15)

1. Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120: 817-820.
2. Kovacs K, Horvath E. Pathology of pituitary tumors. Endocrinol Metab Clin North Am 1987; 16: 529-551.
3. Biller BM, Swearingen B, Zervas NT, Klibanski A. A decade of the Massachusetts General Hospital Neuroendocrine Clinical Center. J Clin Endocrinol Metab 1997; 82: 1668-1674.
4. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev 2006; 27: 485-534.
5. Karavitaki N, Thanabalasingham G, Shore HC, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 2006; 65: 524-529.
6. Molitch ME. Clinical review 65. Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 1995; 80: 3-6.
7. Lamberts SW, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 1998; 352: 127-134.
8. Arafah BM, Kailani SH, Nekl KE, et al. Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 1994; 79: 348-354.
9. Donovan J, Nesbit G. Distinction of masses involving the sella and suprasellar space: specificity of imaging features. AJR Am J Roentgenol 1996; 167: 597-603.
10. Kristof RA, Van Roost D, Klingmuller D, et al. Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy? J Neurol Neurosurg Psychiatry 1999; 67: 398-402.
11. Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000; 85: 1370-1376.
12. Silvani A, Eoli M, Salmaggi A, et al. Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study. J Neurooncol 2005; 71: 271-276.
13. Barker FG 2nd, Klibanski A, Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003; 88: 4709-4719.
14. Clayton RN. How many surgeons to operate on acromegalic patients? Clin Endocrinol (Oxf) 1999; 50: 557-559.
15. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon. QJM 1999; 92: 741-745.